Cytosorbents Corporation - Common Stock — Quarterly Financial Statistics (NASDAQ:CTSO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -3.46 M-1.51 M-2.58 M-4.83 M-1.16 M -10.07 M Cash from investing activities -47.24 K-132 K55 K-291 K-46 K -414 K Cash from financing activities 6.83 M002.48 M6.83 M — Free cash flow -3.46 M-1.51 M-2.58 M-4.83 M-1.16 M -10.07 M

News

Cytosorbents Corporation (CTSO) Presents at Life Sciences Virtual Investor Forum - Slideshow (NASDAQ:CTSO) 2026-06-27

CytoSorbents reports Q4 and full-year 2025 revenue expectations

Cytosorbents Corporation (CTSO) Discusses Progress in Blood-Purification Programs and DrugSorb-ATR's Regulatory Path Transcript

Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript

Cytosorbents Crp earnings beat by $0.01, revenue fell short of estimates

Disney, Brookfield, Nu Holdings and more set to report earnings Thursday

CytoSorbents at H.C. Wainwright: Strategic Growth and Regulatory Challenges

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Color Star Tech (NASDAQ:ADD), Aspen Insurance Hldgs (NYSE:AHL)

FDA upholds denial of CytoSorbents’ DrugSorb-ATR device, offers path forward

Cytosorbents stock plunges after regulatory setbacks for key device

CytoSorbents receives FDA appeal hearing date for DrugSorb-ATR device

CytoSorbents files appeal with FDA over denied device application